Skip to Content

Pressure BioSciences Inc PBIO

Morningstar Rating
$0.25 0.00 (0.12%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PBIO is trading at a 49% discount.
Price
$0.25
Fair Value
$4.69
Uncertainty
Extreme
1-Star Price
$8.74
5-Star Price
$7.45
Economic Moat
Jklw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PBIO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.25
Day Range
$0.220.25
52-Week Range
$0.141.15
Bid/Ask
$0.22 / $0.27
Market Cap
$6.44 Mil
Volume/Avg
43,225 / 98,535

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.03
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of innovative, enabling, pressure-based platform solutions for the worldwide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
17

Valuation

Metric
PBIO
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
2.03
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PBIO
Quick Ratio
0.01
Current Ratio
0.03
Interest Coverage
−0.32
Quick Ratio
PBIO

Profitability

Metric
PBIO
Return on Assets (Normalized)
−1,154.28%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
PBIO
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesTprqqrcTkjdlr$189.5 Bil
SYK
Stryker CorpMwkshsyhjlWtwt$129.0 Bil
MDT
Medtronic PLCMcdgtqfgWjwtzst$105.2 Bil
BSX
Boston Scientific CorpTsdbphvTklfz$100.1 Bil
EW
Edwards Lifesciences CorpZprmypgvcCprzgd$53.7 Bil
DXCM
DexCom IncGppjfyqmbWxbg$51.9 Bil
ZBH
Zimmer Biomet Holdings IncQwwbchjgFqnm$25.1 Bil
ALGN
Align Technology IncWzybfgyvZkgvbh$23.0 Bil
PHG
Koninklijke Philips NV ADRHdtnndnyrXpmwlh$18.7 Bil
PODD
Insulet CorpKjxxbypfvTzwrhw$12.1 Bil

Sponsor Center